MetLife Investment Management’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,523
Closed -$130K 2337
2020
Q4
$130K Hold
4,523
﹤0.01% 2182
2020
Q3
$135K Buy
+4,523
New +$137K ﹤0.01% 2076

Other funds holding AFIB

MetLife Investment Management's AFIB Position: Q1 2021 in Review

MetLife Investment Management sold out of Acutus Medical Inc (AFIB) in Q1 2021, closing a stake of 4,523 shares — an estimated $130K sold.

MetLife Investment Management first reported a position in AFIB in Q3 2020 and held it in 2 quarters. The position peaked at $135K in Q3 2020. 67 funds tracked by Wall St. Rank hold AFIB as of Q1 2021.

  • MetLife Investment Management reported no remaining Acutus Medical Inc position as of Q1 2021 after selling out during the quarter.
  • MetLife Investment Management sold 4,523 Acutus Medical Inc shares in Q1 2021, an estimated $130K.
  • MetLife Investment Management first reported a position in Acutus Medical Inc in Q3 2020 and held it in 2 quarters.
  • MetLife Investment Management's Acutus Medical Inc position peaked at $135K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2021.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.